Zentalis Pharmaceuticals (ZNTL) Interest Expenses (2019 - 2021)

Zentalis Pharmaceuticals (ZNTL) recorded quarterly Interest Expenses of $44000.0 in Q1 2021, up 266.67% quarter-over-quarter from $12000.0 in Q1 2019.

Zentalis Pharmaceuticals (ZNTL) Interest Expenses (2019 - 2021) Analysis & Trends

Zentalis Pharmaceuticals' Interest Expenses history runs 2 years deep, the most recent figure standing at $44000.0 for Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -5.50 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 61,000.00
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -332,000.00
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -2,753.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -5.58 Mn
10 Zentalis Pharmaceuticals 264.90 Mn 264.90 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2021 44,000.00
Mar 31, 2021 44,000.00
Mar 31, 2019 12,000.00
Mar 31, 2019 12,000.00